All abstracts in PDF format (right click and "Save link as...")
SPEAKER SESSIONS
POSTER SESSIONS (P)
-
Basic Science
- p58 Etiology, genetics, epidemiology and toxicants
- p69 Cell death, neuroprotection and trophic factors
- p73 Protein misfolding and handling
- p78 Mitochondria, oxidative stress, and pathogens
- p91 Pathology
- p96 Animal and cellular models of Parkinson’s disease and Parkinsonisms
- p116 Brain physiology and circuitry
- p118 Dopamine, receptors, and other neurotransmitters
- p121 Neuropharmacology
- p124 Electrophysiology and functional imaging, optogenetics
- p127 Prevention, neuroprotection neuroplasticity
-
Comprehensive Care
- p130 Caregiving, relationships, respite care, families
- p135 Exercise and physical activity
- p149 Alternative & complementary therapies/Creativity
- p158 Lay/professional health literacy & public thought
- p161 Disability and quality of life outcome measures
- p166 PwP – Clinician partnership: Shared decision-making
- p168 Palliative Care/Advanced Planning/End of Life Care
- p170 Health accessibility/Underserved populations
- p174 Sexuality & Intimacy
- p176 Daily life activities including working & driving
- p177 Self-management, empowerment, coping strategies
- p184 Multidisciplinary/Interdisciplinary teams
- p191 Digital health, E-health and technology
- p204 Rehabilitation sciences (PT, OT, SLP)
- p224 Nutrition and gastrointestinal issues
-
Clinical Science
- p226 Symptoms, signs, features & non-motor manifestations
- p241 Progression & prognosis
- p245 Behavioral disorders
- p247 Cognition/Mood/Memory
- p257 Sleep disorders/Fatigue
- p259 Diagnosis (differential, accuracy)
- p262 Co-morbidities
- p265 Biomarkers and neuroimaging
- p275 Pharmacological therapy
- p281 Surgical therapy, including cell and gene therapy
- p288 Complications of therapies
- p290 Clinical trials: Design, outcomes, recruiting etc.
- p306 Rating scales
- p308 E-health and technology
- p315 Neuroimaging
- p319 Prodromal
-
Living with Parkinson's
LATE-BREAKING POSTERS (LBP)
-
Basic Science
- p361 Etiology, genetics, epidemiology and toxicants
- p362 Protein misfolding and handling
- p363 Pathology
- p364 Animal and cellular models of Parkinson’s disease and Parkinsonisms
- p370 Dopamine, receptors, and other neurotransmitters
- p371 Neuropharmacology
- p371 Electrophysiology and functional imaging, optogenetics
-
Comprehensive Care
- p371 Caregiving, relationships, respite care, families
- p372 Exercise and physical activity
- p373 Health accessibility/Underserved populations
- p374 Self-management, empowerment, coping strategies
- p374 Multidisciplinary/Interdisciplinary teams
- p375 Digital health, E-health and technology
- p377 Rehabilitation sciences (PT, OT, SLP)
- p377 Nutrition and gastrointestinal issues
-
Clinical Science
- p378 Symptoms, signs, features & non-motor manifestations
- p378 Progression & prognosis
- p379 Sleep disorders/Fatigue
- p379 Diagnosis (differential, accuracy)
- p380 Biomarkers and neuroimaging
- p381 Pharmacological therapy
- p381 Surgical therapy, including cell and gene therapy
- p382 Clinical trials: Design, outcomes, recruiting etc.
- p386 Rating scales
- p386 E-health and technology
-
Living with Parkinson's